nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefpodoxime—Cefdinir—MPO—chronic obstructive pulmonary disease	0.00465	0.339	CrCbGaD
Cefpodoxime—Cefaclor—MPO—chronic obstructive pulmonary disease	0.00461	0.336	CrCbGaD
Cefpodoxime—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.00184	0.00186	CcSEcCtD
Cefpodoxime—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.00184	0.00186	CcSEcCtD
Cefpodoxime—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.00184	0.00186	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.00182	0.00185	CcSEcCtD
Cefpodoxime—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.00182	0.00185	CcSEcCtD
Cefpodoxime—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00181	0.00184	CcSEcCtD
Cefpodoxime—Cough—Formoterol—chronic obstructive pulmonary disease	0.00181	0.00184	CcSEcCtD
Cefpodoxime—Cough—Arformoterol—chronic obstructive pulmonary disease	0.00181	0.00184	CcSEcCtD
Cefpodoxime—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.0018	0.00183	CcSEcCtD
Cefpodoxime—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.0018	0.00182	CcSEcCtD
Cefpodoxime—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.0018	0.00182	CcSEcCtD
Cefpodoxime—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.00179	0.00182	CcSEcCtD
Cefpodoxime—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.00179	0.00182	CcSEcCtD
Cefpodoxime—Skin exfoliation—Prednisone—chronic obstructive pulmonary disease	0.00179	0.00181	CcSEcCtD
Cefpodoxime—Cough—Montelukast—chronic obstructive pulmonary disease	0.00178	0.0018	CcSEcCtD
Cefpodoxime—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00177	0.00179	CcSEcCtD
Cefpodoxime—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.00177	0.00179	CcSEcCtD
Cefpodoxime—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.00177	0.00179	CcSEcCtD
Cefpodoxime—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.00177	0.00179	CcSEcCtD
Cefpodoxime—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.00177	0.00179	CcSEcCtD
Cefpodoxime—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.00177	0.00179	CcSEcCtD
Cefpodoxime—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.00176	0.00179	CcSEcCtD
Cefpodoxime—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.00176	0.00179	CcSEcCtD
Cefpodoxime—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.00176	0.00179	CcSEcCtD
Cefpodoxime—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.00176	0.00179	CcSEcCtD
Cefpodoxime—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.00176	0.00179	CcSEcCtD
Cefpodoxime—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.00176	0.00179	CcSEcCtD
Cefpodoxime—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.00176	0.00178	CcSEcCtD
Cefpodoxime—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00175	0.00177	CcSEcCtD
Cefpodoxime—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.00175	0.00177	CcSEcCtD
Cefpodoxime—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.00173	0.00176	CcSEcCtD
Cefpodoxime—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.00173	0.00176	CcSEcCtD
Cefpodoxime—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.00173	0.00175	CcSEcCtD
Cefpodoxime—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.00173	0.00175	CcSEcCtD
Cefpodoxime—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.00173	0.00175	CcSEcCtD
Cefpodoxime—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.00172	0.00175	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00172	0.00174	CcSEcCtD
Cefpodoxime—Dry skin—Prednisolone—chronic obstructive pulmonary disease	0.00171	0.00174	CcSEcCtD
Cefpodoxime—Cough—Salbutamol—chronic obstructive pulmonary disease	0.00171	0.00174	CcSEcCtD
Cefpodoxime—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.0017	0.00172	CcSEcCtD
Cefpodoxime—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.0017	0.00172	CcSEcCtD
Cefpodoxime—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.00169	0.00172	CcSEcCtD
Cefpodoxime—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.00167	0.00169	CcSEcCtD
Cefpodoxime—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.00167	0.00169	CcSEcCtD
Cefpodoxime—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00167	0.00169	CcSEcCtD
Cefpodoxime—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.00166	0.00169	CcSEcCtD
Cefpodoxime—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.00166	0.00168	CcSEcCtD
Cefpodoxime—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.00166	0.00168	CcSEcCtD
Cefpodoxime—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00165	0.00167	CcSEcCtD
Cefpodoxime—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00164	0.00166	CcSEcCtD
Cefpodoxime—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.00163	0.00166	CcSEcCtD
Cefpodoxime—Hyperkinesia—Prednisone—chronic obstructive pulmonary disease	0.00163	0.00165	CcSEcCtD
Cefpodoxime—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.00163	0.00165	CcSEcCtD
Cefpodoxime—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.00163	0.00165	CcSEcCtD
Cefpodoxime—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.0016	0.00162	CcSEcCtD
Cefpodoxime—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.00158	0.00161	CcSEcCtD
Cefpodoxime—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.00158	0.00161	CcSEcCtD
Cefpodoxime—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00158	0.0016	CcSEcCtD
Cefpodoxime—Shock—Salbutamol—chronic obstructive pulmonary disease	0.00158	0.0016	CcSEcCtD
Cefpodoxime—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.00157	0.00159	CcSEcCtD
Cefpodoxime—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00155	0.00157	CcSEcCtD
Cefpodoxime—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.00155	0.00157	CcSEcCtD
Cefpodoxime—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.00154	0.00157	CcSEcCtD
Cefpodoxime—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00154	0.00157	CcSEcCtD
Cefpodoxime—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.00153	0.00155	CcSEcCtD
Cefpodoxime—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.00153	0.00155	CcSEcCtD
Cefpodoxime—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.00153	0.00155	CcSEcCtD
Cefpodoxime—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00152	0.00155	CcSEcCtD
Cefpodoxime—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.00151	0.00153	CcSEcCtD
Cefpodoxime—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.00151	0.00153	CcSEcCtD
Cefpodoxime—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.00151	0.00153	CcSEcCtD
Cefpodoxime—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.00151	0.00153	CcSEcCtD
Cefpodoxime—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.00151	0.00153	CcSEcCtD
Cefpodoxime—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.0015	0.00152	CcSEcCtD
Cefpodoxime—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.0015	0.00152	CcSEcCtD
Cefpodoxime—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.0015	0.00152	CcSEcCtD
Cefpodoxime—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.00149	0.00151	CcSEcCtD
Cefpodoxime—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.00149	0.00151	CcSEcCtD
Cefpodoxime—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.00149	0.00151	CcSEcCtD
Cefpodoxime—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00149	0.00151	CcSEcCtD
Cefpodoxime—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.00148	0.0015	CcSEcCtD
Cefpodoxime—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00147	0.00149	CcSEcCtD
Cefpodoxime—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.00147	0.00149	CcSEcCtD
Cefpodoxime—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00146	0.00148	CcSEcCtD
Cefpodoxime—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00146	0.00148	CcSEcCtD
Cefpodoxime—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.00146	0.00148	CcSEcCtD
Cefpodoxime—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.00146	0.00148	CcSEcCtD
Cefpodoxime—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.00146	0.00148	CcSEcCtD
Cefpodoxime—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00146	0.00148	CcSEcCtD
Cefpodoxime—Pain—Formoterol—chronic obstructive pulmonary disease	0.00145	0.00147	CcSEcCtD
Cefpodoxime—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.00145	0.00147	CcSEcCtD
Cefpodoxime—Pain—Arformoterol—chronic obstructive pulmonary disease	0.00145	0.00147	CcSEcCtD
Cefpodoxime—Constipation—Formoterol—chronic obstructive pulmonary disease	0.00145	0.00147	CcSEcCtD
Cefpodoxime—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.00145	0.00147	CcSEcCtD
Cefpodoxime—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00144	0.00146	CcSEcCtD
Cefpodoxime—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00143	0.00145	CcSEcCtD
Cefpodoxime—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.00143	0.00145	CcSEcCtD
Cefpodoxime—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.00143	0.00145	CcSEcCtD
Cefpodoxime—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.00142	0.00144	CcSEcCtD
Cefpodoxime—Pain—Montelukast—chronic obstructive pulmonary disease	0.00142	0.00144	CcSEcCtD
Cefpodoxime—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00142	0.00144	CcSEcCtD
Cefpodoxime—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.00141	0.00143	CcSEcCtD
Cefpodoxime—Rash—Aminophylline—chronic obstructive pulmonary disease	0.0014	0.00142	CcSEcCtD
Cefpodoxime—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.0014	0.00142	CcSEcCtD
Cefpodoxime—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.0014	0.00142	CcSEcCtD
Cefpodoxime—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.0014	0.00142	CcSEcCtD
Cefpodoxime—Headache—Aminophylline—chronic obstructive pulmonary disease	0.0014	0.00142	CcSEcCtD
Cefpodoxime—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.00139	0.00141	CcSEcCtD
Cefpodoxime—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00139	0.00141	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.00139	0.00141	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.00139	0.00141	CcSEcCtD
Cefpodoxime—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00138	0.0014	CcSEcCtD
Cefpodoxime—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.00138	0.0014	CcSEcCtD
Cefpodoxime—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.00137	0.00139	CcSEcCtD
Cefpodoxime—Pain—Salbutamol—chronic obstructive pulmonary disease	0.00137	0.00139	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.00136	0.00138	CcSEcCtD
Cefpodoxime—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.00135	0.00137	CcSEcCtD
Cefpodoxime—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.00135	0.00137	CcSEcCtD
Cefpodoxime—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00134	0.00136	CcSEcCtD
Cefpodoxime—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.00134	0.00136	CcSEcCtD
Cefpodoxime—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.00134	0.00136	CcSEcCtD
Cefpodoxime—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00134	0.00136	CcSEcCtD
Cefpodoxime—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00134	0.00135	CcSEcCtD
Cefpodoxime—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00132	0.00134	CcSEcCtD
Cefpodoxime—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00132	0.00134	CcSEcCtD
Cefpodoxime—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00132	0.00134	CcSEcCtD
Cefpodoxime—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.00132	0.00134	CcSEcCtD
Cefpodoxime—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.00132	0.00134	CcSEcCtD
Cefpodoxime—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00132	0.00133	CcSEcCtD
Cefpodoxime—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.00131	0.00133	CcSEcCtD
Cefpodoxime—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.00131	0.00133	CcSEcCtD
Cefpodoxime—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.00131	0.00133	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.00131	0.00133	CcSEcCtD
Cefpodoxime—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.0013	0.00132	CcSEcCtD
Cefpodoxime—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.00129	0.00131	CcSEcCtD
Cefpodoxime—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.00127	0.00129	CcSEcCtD
Cefpodoxime—Cefazolin—ALB—chronic obstructive pulmonary disease	0.00127	0.0922	CrCbGaD
Cefpodoxime—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.00127	0.00128	CcSEcCtD
Cefpodoxime—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.00127	0.00128	CcSEcCtD
Cefpodoxime—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.00125	0.00127	CcSEcCtD
Cefpodoxime—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.00125	0.00127	CcSEcCtD
Cefpodoxime—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00125	0.00127	CcSEcCtD
Cefpodoxime—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.00124	0.00126	CcSEcCtD
Cefpodoxime—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00122	0.00124	CcSEcCtD
Cefpodoxime—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.00122	0.00123	CcSEcCtD
Cefpodoxime—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.00122	0.00123	CcSEcCtD
Cefpodoxime—Ceftriaxone—ALB—chronic obstructive pulmonary disease	0.0012	0.0874	CrCbGaD
Cefpodoxime—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.0012	0.00122	CcSEcCtD
Cefpodoxime—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.0012	0.00122	CcSEcCtD
Cefpodoxime—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.0012	0.00121	CcSEcCtD
Cefpodoxime—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.00119	0.00121	CcSEcCtD
Cefpodoxime—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.00118	0.0012	CcSEcCtD
Cefpodoxime—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00118	0.0012	CcSEcCtD
Cefpodoxime—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00118	0.00119	CcSEcCtD
Cefpodoxime—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.00116	0.00118	CcSEcCtD
Cefpodoxime—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.00116	0.00118	CcSEcCtD
Cefpodoxime—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00115	0.00116	CcSEcCtD
Cefpodoxime—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.00114	0.00116	CcSEcCtD
Cefpodoxime—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00114	0.00115	CcSEcCtD
Cefpodoxime—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00113	0.00115	CcSEcCtD
Cefpodoxime—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00112	0.00114	CcSEcCtD
Cefpodoxime—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00112	0.00114	CcSEcCtD
Cefpodoxime—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.0011	0.00111	CcSEcCtD
Cefpodoxime—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.0011	0.00111	CcSEcCtD
Cefpodoxime—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.0011	0.00111	CcSEcCtD
Cefpodoxime—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00108	0.00109	CcSEcCtD
Cefpodoxime—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00108	0.00109	CcSEcCtD
Cefpodoxime—Rash—Formoterol—chronic obstructive pulmonary disease	0.00107	0.00108	CcSEcCtD
Cefpodoxime—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00107	0.00108	CcSEcCtD
Cefpodoxime—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00107	0.00108	CcSEcCtD
Cefpodoxime—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00107	0.00108	CcSEcCtD
Cefpodoxime—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.00107	0.00108	CcSEcCtD
Cefpodoxime—Headache—Formoterol—chronic obstructive pulmonary disease	0.00106	0.00108	CcSEcCtD
Cefpodoxime—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00106	0.00108	CcSEcCtD
Cefpodoxime—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00106	0.00107	CcSEcCtD
Cefpodoxime—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.00106	0.00107	CcSEcCtD
Cefpodoxime—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00106	0.00107	CcSEcCtD
Cefpodoxime—Cefalotin—ALB—chronic obstructive pulmonary disease	0.00105	0.0765	CrCbGaD
Cefpodoxime—Rash—Montelukast—chronic obstructive pulmonary disease	0.00105	0.00106	CcSEcCtD
Cefpodoxime—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00105	0.00106	CcSEcCtD
Cefpodoxime—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.00104	0.00106	CcSEcCtD
Cefpodoxime—Headache—Montelukast—chronic obstructive pulmonary disease	0.00104	0.00105	CcSEcCtD
Cefpodoxime—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00102	0.00103	CcSEcCtD
Cefpodoxime—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.00101	0.00103	CcSEcCtD
Cefpodoxime—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.00101	0.00102	CcSEcCtD
Cefpodoxime—Rash—Salbutamol—chronic obstructive pulmonary disease	0.00101	0.00102	CcSEcCtD
Cefpodoxime—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.00101	0.00102	CcSEcCtD
Cefpodoxime—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.00101	0.00102	CcSEcCtD
Cefpodoxime—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00101	0.00102	CcSEcCtD
Cefpodoxime—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00101	0.00102	CcSEcCtD
Cefpodoxime—Headache—Salbutamol—chronic obstructive pulmonary disease	0.001	0.00102	CcSEcCtD
Cefpodoxime—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000989	0.001	CcSEcCtD
Cefpodoxime—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000986	0.001	CcSEcCtD
Cefpodoxime—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000975	0.000988	CcSEcCtD
Cefpodoxime—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000971	0.000985	CcSEcCtD
Cefpodoxime—Cephalexin—ALB—chronic obstructive pulmonary disease	0.000956	0.0696	CrCbGaD
Cefpodoxime—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000951	0.000964	CcSEcCtD
Cefpodoxime—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000946	0.00096	CcSEcCtD
Cefpodoxime—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000944	0.000957	CcSEcCtD
Cefpodoxime—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000939	0.000952	CcSEcCtD
Cefpodoxime—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000935	0.000948	CcSEcCtD
Cefpodoxime—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000918	0.000931	CcSEcCtD
Cefpodoxime—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000903	0.000916	CcSEcCtD
Cefpodoxime—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000888	0.0009	CcSEcCtD
Cefpodoxime—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000831	0.000842	CcSEcCtD
Cefpodoxime—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.00083	0.000842	CcSEcCtD
Cefpodoxime—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000825	0.000836	CcSEcCtD
Cefpodoxime—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000785	0.000796	CcSEcCtD
Cefpodoxime—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000759	0.000769	CcSEcCtD
Cefpodoxime—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000757	0.000767	CcSEcCtD
Cefpodoxime—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000756	0.000766	CcSEcCtD
Cefpodoxime—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000751	0.000762	CcSEcCtD
Cefpodoxime—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000737	0.000748	CcSEcCtD
Cefpodoxime—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000735	0.000745	CcSEcCtD
Cefpodoxime—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000733	0.000743	CcSEcCtD
Cefpodoxime—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.00073	0.00074	CcSEcCtD
Cefpodoxime—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000719	0.000729	CcSEcCtD
Cefpodoxime—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000708	0.000718	CcSEcCtD
Cefpodoxime—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000706	0.000716	CcSEcCtD
Cefpodoxime—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000696	0.000706	CcSEcCtD
Cefpodoxime—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000694	0.000703	CcSEcCtD
Cefpodoxime—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000688	0.000697	CcSEcCtD
Cefpodoxime—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000677	0.000686	CcSEcCtD
Cefpodoxime—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000667	0.000677	CcSEcCtD
Cefpodoxime—Shock—Prednisone—chronic obstructive pulmonary disease	0.000657	0.000666	CcSEcCtD
Cefpodoxime—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000645	0.000654	CcSEcCtD
Cefpodoxime—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000636	0.000645	CcSEcCtD
Cefpodoxime—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000608	0.000616	CcSEcCtD
Cefpodoxime—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000607	0.000616	CcSEcCtD
Cefpodoxime—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000604	0.000612	CcSEcCtD
Cefpodoxime—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000599	0.000608	CcSEcCtD
Cefpodoxime—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000587	0.000596	CcSEcCtD
Cefpodoxime—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.00058	0.000588	CcSEcCtD
Cefpodoxime—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000579	0.000587	CcSEcCtD
Cefpodoxime—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000578	0.000587	CcSEcCtD
Cefpodoxime—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000575	0.000583	CcSEcCtD
Cefpodoxime—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000575	0.000583	CcSEcCtD
Cefpodoxime—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000571	0.000579	CcSEcCtD
Cefpodoxime—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.00055	0.000558	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000546	0.000553	CcSEcCtD
Cefpodoxime—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000545	0.000553	CcSEcCtD
Cefpodoxime—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.00053	0.000537	CcSEcCtD
Cefpodoxime—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000528	0.000535	CcSEcCtD
Cefpodoxime—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000528	0.000535	CcSEcCtD
Cefpodoxime—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000492	0.000498	CcSEcCtD
Cefpodoxime—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000479	0.000485	CcSEcCtD
Cefpodoxime—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000472	0.000479	CcSEcCtD
Cefpodoxime—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000457	0.000463	CcSEcCtD
Cefpodoxime—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000441	0.000447	CcSEcCtD
Cefpodoxime—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000424	0.00043	CcSEcCtD
Cefpodoxime—Rash—Prednisone—chronic obstructive pulmonary disease	0.000421	0.000427	CcSEcCtD
Cefpodoxime—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.00042	0.000426	CcSEcCtD
Cefpodoxime—Headache—Prednisone—chronic obstructive pulmonary disease	0.000418	0.000424	CcSEcCtD
Cefpodoxime—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000396	0.000402	CcSEcCtD
